Actively Recruiting

Phase Not Applicable
Age: 4Years - 17Years
All Genders
NCT07273019

Tongue Muscular Assessment in Children With Sleep Disordered Breathing

Led by Hospices Civils de Lyon · Updated on 2026-03-27

78

Participants Needed

1

Research Sites

78 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Obstructive sleep apnea (OSA) is part of the sleep-disordered breathing spectrum. Its prevalence in children is 1-5%, and it can have negative consequences at the cardiovascular, cognitive as well as behavioral levels. In children, the first-line treatment is adenotonsillectomy. However, residual obstructive events can persist as the success rate of surgery reaches only 49% in non-obese children. Residual OSA may be explained by multiple sites of obstruction, found in 20-85% children concerned by persistent OSA. Indeed, the tongue appears among one possible primary sites of obstruction. Given the tongue's crucial role in upper-airway patency during sleep, its assessment can inform us about the myofunctional deficits involved in sleep-disordered breathing. The primary objective of the present study is to assess tongue motor functions in children with sleep-disordered breathing and to compare them to those of healthy children (data collected in a current study (TMAC) conducted at UCLouvain, Belgium; NCT06166680), in order to document possible myofunctional deficits in children with OSA. The hypothesis is that tongue motor functions will be lower in children with sleep-disordered breathing.

CONDITIONS

Official Title

Tongue Muscular Assessment in Children With Sleep Disordered Breathing

Who Can Participate

Age: 4Years - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Suspected sleep-disordered breathing
  • Referred for polysomnography
  • Affiliated with a social security scheme
  • Informed consent obtained from both legal representatives
Not Eligible

You will not qualify if you...

  • Insufficient comprehension of French language
  • For suspected OSA type I or II: neurological, cardiac, or respiratory conditions other than sleep disorders
  • Deficits possibly affecting measurements (e.g., psychiatric conditions)
  • Previous surgery on upper airway or oral cavity
  • Malformations of skull, upper airway, or oral cavity
  • For suspected OSA type III: deficits impacting measurements (e.g., psychiatric conditions)
  • Intellectual deficit preventing understanding of instructions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hôpital Femme-Mère-Enfant : Service d'épileptologie clinique, des troubles du sommeil et de neurologie fonctionnelle de l'enfant

Bron, France, 69500

Actively Recruiting

Loading map...

Research Team

P

Patricia FRANCO, MD, PhD

CONTACT

A

Aurore GUYON, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here